Show simple item record

dc.creatorDivakaran Prathapan, Kaniyarikkal
dc.creatorPethiyagoda, Rohan
dc.creatorBawa Singh, Kamaljit
dc.creatorRaven, Peter H.
dc.creatorRajan, Priyadarsanan Dharma
dc.date.accessioned2023-01-24T23:40:27Z
dc.date.available2023-01-24T23:40:27Z
dc.date.issued2018-06-29
dc.identifier.citationDivakaran Prathapan, K., Pethiyagoda, R., Bawa Singh, K., Raven, P. H., y Rajan, P. D. (2018). When the cure kills—CBD limits biodiversity research : national laws fearing biopiracy squelch taxonomy studies. Science. Estados Unidos: AAAS; 360 (6396), pp. 1405-1406.es_AR
dc.identifier.issn1095-9203
dc.identifier.otherCCPI-CNyE-A-019
dc.identifier.other6354
dc.identifier.urihttps://hdl.handle.net/20.500.12219/4323
dc.descriptionFil: Divakaran Prathapan, Kaniyarikkal. Universidad Agrícola de Kerala; India.es_AR
dc.descriptionFil: Pethiyagoda, Rohan. Museo Australiano. Sección de Ictiología; Australia.es_AR
dc.descriptionFil: Bawa Singh, Kamaljit. Universidad de Massachusetts; Estados Unidos.es_AR
dc.descriptionFil: Raven, Peter H. Jardín Botánico de Missouri; Estados Unidos.es_AR
dc.descriptionFil: Rajan, Priyadarsanan Dharma. Ashoka Trust for Research in Ecology and the Environment; India.es_AR
dc.description.abstractThe Convention on Biological Diversity (CBD) commits its 196 nation parties to conserve biological diversity, use its components sustainably, and share fairly and equitably the benefits from the utilization of genetic resources. The last of these objectives was further codified in the Convention's Nagoya Protocol (NP), which came into effect in 2014. Although these aspirations are laudable, the NP and resulting national ambitions on Access and Benefit Sharing (ABS) of genetic resources have generated several national regulatory regimes fraught with unintended consequences (1). Anticipated benefits from the commercial use of genetic resources, especially those that might flow to local or indigenous communities because of regulated access to those resources, have largely been exaggerated and not yet realized. Instead, national regulations created in anticipation of commercial benefits, particularly in many countries that are rich in biodiversity, have curtailed biodiversity research by in-country scientists as well as international collaboration (1). This weakens the first and foremost objective of the CBD—conservation of biological diversity. We suggest ways that the Conference of the Parties (CoP) of the CBD may proactively engage scientists to create a regulatory environment conducive to advancing biodiversity science.en
dc.formatapplication/pdf
dc.format.extent592.3 KB
dc.language.isoengen
dc.publisherAmerican Association for the Advancement of Sciencees_AR
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://science.sciencemag.org/content/360/6396/1405
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectNagoya Protocolen
dc.subjectPicen
dc.subjectConservationen
dc.subjectTaxonomyen
dc.titleWhen the cure kills—CBD limits biodiversity research : national laws fearing biopiracy squelch taxonomy studiesen
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess